Fate Therapeutics Inc
FATE
NASDAQ
Biotechnology
$2.57
USD
+0.05 (+1.98%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $293.73M
Volume 2.0M
Price Target
$7.00 – $7.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $7.00 and a min estimate of $7.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$7.00
Unchanged vs prior
Implied Upside
+172.4%
Unchanged vs prior
Analyst Covering
1
Unchanged vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
50%
A mix of recent and older ratings shape this consensus
Analyst Agreement
High
Targets are closely clustered - analysts largely agree
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Robert Burns | HC Wainwright & Co. | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
TLSI
TriSalus Life Sciences Inc
$5.27
▼ -6.4%
SION
Sionna Therapeutics Inc
$6.46
▼ -1.2%
AVXL
Anavex Life Sciences Corp
$3.22
▼ -1.5%
IRD
Opus Genetics Inc
$3.61
▼ -3.0%
ANIK
Anika Therapeutics Inc
$21.50
▲ +1.6%
VNDA
Vanda Pharmaceuticals Inc
$5.22
▲ +3.8%
CAMP
CAMP4 Therapeutics Corp
$5.44
▲ +20.9%
MYGN
Myriad Genetics Inc
$3.03
▼ -4.4%
TRDA
Entrada Therapeutics Inc
$7.46
▲ +0.1%